NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

Viatris emerged from Pfizer's merger with Mylan and Upjohn, trading since 2020, with a market cap of $11 billion. See why I ...

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...

Viatris Inc. missed sales/EPS estimates with 2025 guidance showing challenges like a $385M EBITDA hit. Learn why experts suggest avoiding VTRS stock.

On Friday, Jefferies analyst Glen Santangelo adjusted the price target for Viatris (NASDAQ:VTRS) stock, bringing it down to $13.00 from the previous $15.00 while maintaining a Buy rating on the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...